rationale acute exacerbations aes chronic obstructive pulmonary disease copd major cause morbidity mortality copd objectives marked heterogeneity host defense mechanisms attributed single nucleotide polymorphisms snps inflammatory chemokines enhanced expression airway patients copd experience aes methods investigated snps ccl11 ccl1 ccl5 genes relation frequency severity aes retrospective prospective studies cohort NUMBER male patients copd measurements main results retrospective study snp national center biotechnology information snp reference rs2282691 predicted enhancer region ccl1 gene encoding chemotactic factor series leukocytes significantly associated frequency aes dominant model fishers exact test odds ratio NUMBER NUMBER confidence interval ci p0004 logistic regression NUMBER NUMBER ci p0003 test p0003 prospective study allele significant risk allele severity aes effect method test aa vs tt statistic NUMBER p0006 cox proportional hazards regression method NUMBER NUMBER ci p0023 electromobility shift assay showed key transcriptional factor response pulmonary infections binds t allele allele conclusions variants ccl1 gene associated susceptibility aes potential implication host defense mechanisms aes NUMBER yr NUMBER NUMBER NUMBER NUMBER kruskal wallis NUMBER mo gene dosage kaplan meier log rank log rank NUMBER NUMBER c ebpbeta